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Abstract: Epidemiological studies have found a positive association between coffee consumption and
a lower risk of cardiovascular disorders, some cancers, diabetes, Parkinson and Alzheimer disease.
Coffee consumption, however, has also been linked to an increased risk of developing some types
of cancer, including bladder cancer in adults and leukemia in children of mothers who drink coffee
during pregnancy. Since cancer is driven by the accumulation of DNA alterations, the ability of the
coffee constituent caffeic acid to induce DNA damage in cells may play a role in the carcinogenic
potential of this beverage. This carcinogenic potential may be exacerbated in cells with DNA repair
defects. People with the genetic disease Fanconi Anemia have DNA repair deficiencies and are
predisposed to several cancers, particularly acute myeloid leukemia. Defects in the DNA repair
protein Fanconi Anemia D2 (FANCD2) also play an important role in the development of a variety
of cancers (e.g., bladder cancer) in people without this genetic disease. This communication shows
that cells deficient in FANCD2 are hypersensitive to the cytotoxicity (clonogenic assay) and DNA
damage (γ-H2AX and 53BP1 focus assay) induced by caffeic acid and by a commercial lyophilized
coffee extract. These data suggest that people with Fanconi Anemia, or healthy people who develop
sporadic mutations in FANCD2, may be hypersensitive to the carcinogenic activity of coffee.
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1. Introduction
Coffee, one of the most widely consumed beverages in the world, can affect human health.
Observational studies suggest that coffee consumption may lower the risk of developing diabetes,
cardiovascular disorders, cirrhosis, and degenerative disorders such as Parkinson and Alzheimer
disease [1,2]. Coffee consumption has also been associated with a decreased risk of total mortality;
coffee drinkers had a lower risk of death from heart disease, chronic respiratory diseases, diabetes,
pneumonia and influenza, and intentional self-harm [3]. No significant association between coffee
consumption and total cancer mortality was found, however [3]. The effect of coffee consumption
on the risk of cancer is inconclusive; some studies indicate that coffee may reduce the risk of some
types of cancers [4–6], while others suggest that it may increase the risk of developing the disease [6,7].
According to the International Agency for Research on Cancer (IARC), coffee is classified as possibly
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carcinogenic to the human urinary bladder (IARC, Vol. 51). Several recent epidemiological studies
have also revealed that maternal consumption of coffee during pregnancy may be associated with
childhood leukemia [8–11]. A recent meta-analysis found that maternal coffee consumption during
pregnancy significantly increased the risk of childhood acute lymphoblastic leukemia (ALL) and acute
myeloid leukemia (AML) in a dose-response manner [11].
Caffeic acid is present in coffee in low amounts, but it is an important metabolite found in plasma
and urine after coffee consumption [1,12]. In coffee, caffeic acid is typically bound to quinic acid to
form an ester called 5-caffeoylquinic acid or chlorogenic acid [13]. Some studies have shown that
caffeic acid possesses antioxidant and anti-genotoxic activities [14–19]. However, other investigations
have revealed that this polyphenol generates reactive oxygen species (ROS) and produces carcinogenic
effects [20–26]. In vivo studies have also found that diets containing caffeic acid induced tumors in
animals [2]. Caffeic acid is therefore classified as possibly carcinogenic to humans (IARC, Vol. 56).
This carcinogenic activity may be due to its ability to induce DNA damage [21–23], probably through
a pro-oxidant mechanism [22,24–26].
Cancer is a disease caused by the accumulation of DNA alterations in our cells [27–30]. When our
cells suffer DNA alterations, the DNA damage response machinery activates a variety of mechanisms to
repair the damage [3]. These mechanisms are necessary for maintaining the integrity of the DNA, and
therefore provide a fundamental biological barrier against carcinogenesis. Mutations in DNA repair
genes result in the accumulation of cellular DNA damage and in predisposition to cancer. Some people
are born with defects in genes involved in the DNA damage response machinery. People without
germline mutations in DNA repair genes can also acquire them during a possible carcinogenic process.
People with these mutations are particularly sensitive to the carcinogenic activity of compounds that
induce types of DNA damage requiring these genes for repair.
The Fanconi anemia (FA) pathway plays an important role in the repair of several types of DNA
damage, including interstrand crosslink, replication fork stalling and double strand breaks. The FA
protein Fanconi Anemia D2 (FANCD2) is essential for proper functioning of this pathway; this protein
is considered a surrogate marker for FA network activation. Mutations in a cluster of proteins of this
pathway cause Fanconi Anemia, a rare autosomal recessive genetic disease characterized by bone
marrow failure, congenital abnormalities, genomic instability and predisposition to several types of
cancer, particularly acute myeloid leukemia [31–33]. Defects in proteins implicated in this DNA repair
pathway has been described in several kinds of sporadic cancers, including bladder cancer and acute
myeloid leukemia [34–37]. Deficiency in this DNA repair pathway makes cells hypersensitive to the
cytotoxicity and DNA-damaging activities of a variety of agents, including ROS [38–40].
Since caffeic acid induces ROS-mediated DNA damage, and since the FA pathway participates in
the repair of this type of DNA damage, we hypothesized that cells deficient in this pathway would
be more susceptible than normal cells to the DNA-damaging effect of this dietary phytochemical.
We report that human cells deficient in FANCD2 are hypersensitive to the cytotoxicity (clonogenic
assay) and DNA damage (γ-H2AX and 53BP1 focus assay) induced by caffeic acid and by a commercial
lyophilized coffee extract, and discuss the possible relevance of these results.
2. Results
2.1. Cells Deficient in FANCD2 Are Hypersensitive to the Cytotoxicity of Coffee and Caffeic Acid
Cells lacking the FA protein FANCD2 (PD20´/´) and cells complemented with FANCD2
(PD20+/+) were exposed for 4 h to caffeic acid and to a commercial lyophilized coffee extract. After
7 days of recovery in drug-free medium, cell survival was determined with the clonogenic assay.
Figure 1 shows that the survival of cells lacking FANCD2 was significantly lower than that of proficient
cells when exposed to several concentrations of caffeic acid (A) and coffee (B). This means that the
cellular toxicity of coffee and caffeic acid is increased in cells lacking the DNA repair protein FANCD2.
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Data  show  the mean  and  standard deviation  (SD)  from  at  least  3  independent  experiments.  For 
statistical analysis, the t‐test (paired, two‐tailed) was used (* p < 0.05, ** p < 0.01). 
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Figure 1. Cells deficient in Fanconi Ane ia D2 (FA CD2) are hypersensitive to the cytotoxicity of
caffeic acid (A) and a co ercial lyophilized coffee extract (B). Parental PD20 cells with functional
FANCD2 (PD20+/+) and PD20 cells lacking FANCD2 (PD20´/´) were treated with caffeic acid or
coffee for 4 h. Then, the cells were allowed to form colonies in drug-free medium for 7 days, and
the percentage of cell survival with respect to untreated cells was determined with the clonogenic
assay. Data show the mean and standard deviation (SD) from at least 3 independent experiments.
For statistical analysis, the t-test (paired, two-tailed) was used (* p < 0.05, ** p < 0.01).
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were exposed for 4 h to caffeic acid 100 μM or coffee 100 μg/mL, and the levels of γ‐H2AX and 53BP1 
foci were measured with the Immunofluorescence focus assay. In (A), quantification of nuclear foci is 
presented. Data show the mean and standard deviation (SD) from at least 3 independent experiments; 
p>0.05 (t‐test, paired, two‐tailed). Representative micrographs are shown in (B), where γ‐H2AX foci 
appear as green spots, 53BP1 foci appear as orange spots and DAPI (4′,6‐diamidino‐2‐phenylindole)‐
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the percentage of γ‐H2AX foci colocalized with 53BP1 is represented. In (D), representative photographs 
of control cells and cells exposed for 4 h to caffeic acid 100 μM or coffee 100 μg/mL are shown.   
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Figure 2. Cells deficient in FANCD2 (PD20´/´) are more sensitive than non-deficient cells (PD20+/+)
to the DNA damage induced by a commercial lyophilized coffee extract and by caffeic acid. Cells
were exposed for 4 h to caffeic acid 100 µM or coffee 100 µg/mL, and the levels of γ-H2AX
and 53BP1 foci were measured with the Immunofluorescence focus assay. In (A), quantification
of nuclear foci is presented. Data show the mean and standard deviation (SD) from at least
3 independent experiments; p > 0.05 (t-test, paired, two-tailed). Representative micrographs are
shown in (B), where γ-H2AX foci appear as green spots, 53BP1 foci appear as orange spots and
DAPI (41,6-diamidino-2-phenylindole)-stained nucleus appear in blue. γ-H2AX foci colocalized with
53BP1 appear as yellow spots. Pictures were taken with an Olympus BX 61 microscope at 40-fold
magnification (Figure 2B shows the part of the pictures that contained cells). In (C), the percentage of
γ-H2AX foci colocalized with 53BP1 is represented. In (D), representative photographs of control cells
and cells exposed for 4 h to caffeic acid 100 µM or coffee 100 µg/mL are shown.
3. Discussion
Coffee consumption may increase the risk of developing some types of cancer, including bladder
cancer and childhood leukemia. Caffeic acid, a phenolic compound found in plasma and urine after
coffee consumption, may contribute to the carcinogenic potential of coffee. Although the effect of
coffee consumption on the risk of cancer is inconclusive, the International Agency for Research on
Cancer has classified both coffee and caffeic acid as possibly carcinogenic to humans.
The ability of caffeic acid to induce DNA damage in cells [22–26] may play a key role in the
carcinogenic potential of caffeic acid and coffee. It is well-known that dividing cells are more susceptible
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to DNA-damaging agents than non-dividing cells. Because cells divide actively during embryonic
and fetal development, coffee consumption could be particularly carcinogenic during pregnancy.
In addition, the carcinogenic potential of coffee would be higher in cells deficient in particular DNA
repair proteins. Figure 1 shows that cells deficient in FANCD2, a critical DNA repair protein of the
Fanconi Anemia pathway, are hypersensitive to the cytotoxicity of caffeic acid and coffee. This suggests
that coffee and caffeic acid cause more DNA damage in cells deficient in this DNA repair protein.
Figure 2 shows that cells lacking FANCD2 developed higher levels γ-H2AX foci than non-deficient
cells when exposed to coffee and caffeic acid. This suggests that the DNA-damaging effects of coffee
and caffeic acid are increased in cells with defects in the DNA repair protein FANCD2. The levels of
53BP1 foci were also increased in cells lacking FANCD2, therefore indicating that coffee and caffeic acid
induce more DSBs in cells deficient in this DNA repair protein. Together, this data indicate that cells
deficient in FANCD2 are hypersensitive to the cytotoxicity and DNA-damaging activities of caffeic
acid and coffee, and suggest that people with mutations in FANCD2 may be hypersensitive to their
carcinogenic activity.
The bioavailability of caffeic acid in humans is relatively high. The plasma and urinary levels of
caffeic acid in humans after coffee consumption are typically in the nanomolar and low micromolar
range [12,42,43]. For example, a study showed that the peak concentration of caffeic acid in the plasma
of ten healthy adults was 1.1 ˘ 0.9 µM; its concentration in urine was highly variable, ranging from
0.07 to 9.43 µM [5]. Figure 2 shows that the concentration of caffeic acid required to detect DNA
damage in cells is high (100 µM), probably because the sensitivity of the immunofluorescence focus
assay is relatively low. But Figure 1 shows that, when treated with caffeic acid 10 µM, the survival of
cells deficient in the DNA repair protein FANCD2 is approximately 60% of that of untreated cells. This
suggests that caffeic acid 10 µM induces cytotoxic levels of DNA damage, and that non-cytotoxic levels
of DNA damage probably occur at lower concentrations; these concentrations are possibly similar to
those achieved in plasma and urine after coffee consumption.
The high concentrations of caffeic acid detected in the urine of some healthy volunteers after
coffee consumption [6] indicate that this phytochemical can be accumulated in the urinary bladder.
This may explain why coffee is classified as possibly carcinogenic to the human urinary bladder (IARC,
Vol. 51). FANCD2 deficiencies have been described in bladder cancer [34–36]. Together, this supports
the idea that coffee and caffeic acid may increase the risk of bladder cancer, particularly in people with
germline or sporadic mutations in the DNA repair protein FANCD2.
The carcinogenic activity of coffee may be mediated not only by the pro-oxidant activity of caffeic
acid [22,24–26], but also by other pro-oxidant coffee constituents. Several coffee constituents, including
chlorogenic acid and hydroquinone, are known to generate hydrogen peroxide [44–47], and hydrogen
peroxide induces DNA damage and plays a key role in cancer development [48]. The cytotoxicity and
DNA-damaging activities of hydrogen peroxide and other ROS are higher in cells deficient in DNA
repair proteins of the Anemia Fanconi pathway [38–40]. This suggests that the carcinogenic potential
of coffee is mediated by the ability of caffeic acid and other coffee constituents to induce pro-oxidant
DNA damage, and that this carcinogenic potential is higher in cells lacking DNA repair proteins of
the Anemia Fanconi pathway. It is important to clarify that some polyphenols can both prevent and
induce oxidative DNA damage, mainly depending on their concentration. At low concentrations, they
can reduce the levels of ROS and prevent DNA damage. At higher concentrations, however, some
polyphenols (particularly those containing catechol or pyrogallol moieties in their structure, such as
caffeic acid) can generate hydrogen peroxide by an autoxidation mechanism. This mechanism involves
the oxidation of polyphenols to semiquinones in a process in which oxygen is reduced to superoxide
anion and hydrogen peroxide. Through the Fenton reaction, hydrogen peroxide produces hydroxyl
radicals that cause oxidative DNA damage [49,50].
In summary, although the effect of coffee consumption on the risk of cancer is inconclusive,
some studies indicate that coffee may increase the risk of developing some cancers [6,7]. Here we
report that cells deficient in the DNA repair protein FANCD2 are hypersensitive to the cytotoxic and
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DNA-damaging activities of a commercial lyophilized coffee extract and caffeic acid (an important
metabolite found in plasma and urine after coffee consumption). These data suggest that people
with Fanconi Anemia, or healthy people who develop sporadic mutations in FANCD2, may be
hypersensitive to the carcinogenic activity of coffee.
4. Materials and Methods
4.1. Chemicals and Cell Lines
Caffeic acid was purchased from Sigma (ě98.0%, Sigma-Aldrich, St. Louis, MO, USA).
A commercial lyophilized coffee extract (NESCAFÉ® Classic, Barcelona, Spain) was used.
In all experiments, caffeic acid and the coffee extract were tested individually, not mixed together.
The human Fanconi deficient (PD20 FANCD2´/´) and proficient (PD20 FANCD2´/´ complemented
with FANCD2) cells were kindly provided by Dr. Thomas Helleday and by Dr. Jordi Surrallés Calonge.
Cells were maintained in DMEM supplemented with 2 mM glutamine, 50 µg/mL penicillin, 50 µg/mL
streptomycin and 20% fetal bovine serum. Cells were cultured at 37 ˝C in a humidified atmosphere
containing 5% CO2.
4.2. Clonogenic Assay
Cell survival was measured with the clonogenic assay. Cells were plated at low density onto 6 cm
Petri dishes. Cells were treated with caffeic acid or coffee for 4 h; then drugs were removed and fresh
media was added to allow the cells to grow for 7 days. Colonies were stained with methylene blue
prepared in methanol (4 g/L). Surviving colonies made up 50 cells per colony were counted and the
data were corrected according to cloning efficiencies of control cells.
4.3. Immunofluorescence γ-H2AX and 53BP1 Focus Assay
To evaluate DNA damage, detection of γ-H2AX and 53BP1 foci were quantified by
immunofluorescence using the focus assay. The γ-H2AX focus assay is based on the ability of
double-strand breaks (DSBs) to trigger phosphorylation of histone H2AX on Ser-139, which leads to the
formation of nuclear foci that can be visualized with anti-γ-H2AX antibodies. Following the induction
of double strand breaks, formation of γ-H2AX foci is associated with recruitment of p53-binding
protein 1 (53BP1). Accumulation of 53BP1 can also be visualized as foci with anti-53BP1 antibodies.
After treatments, cells were washed three times with PBS, and incubated for 30 s with cold 0.1%
Triton-X in PBS to pre-extract soluble proteins. Afterward, cells were fixed with 4% paraformaldehyde
in PBS for 10 min at room temperature and washed three times with PBS. After fixation, cells were
permeabilized with 0.5% Triton X-100 in PBS for 5 min and then blocked three times with 0.1% Tween
20, 1% BSA in PBS for 5 min each. Cells were then incubated for 1 h with a mouse anti-γ-H2AX
monoclonal antibody (Upstate; 1:800 dilution). Cells were washed three times with PBS and blocked
three times prior to the incubation with a secondary anti-mouse antibody linked to Alexa Fluor 488
(Invitrogen; 1:500 dilution) for 1 h. Cells were washed with PBS, blocked, and incubated overnight
with the rabbit anti-53BP1 primary antibody (Bethyl, 1:1000 dilution). After incubation, cells were
washed with PBS, blocked and washed again with PBS as indicated before. DNA was stained with
DAPI (41,6-diamidino-2-phenylindole) and immunofluorescence was observed at 40-fold magnification
with an Olympus BX 61 microscope. A total of at least 100 cells/dose were scored, and cells with 10 or
more foci were scored as positive [44,51].
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ALL acute lymphoblastic leukemia
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